Blog
About

21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Functional characterization of human variants of NFKBIA: a key regulator of immune responsiveness implicated in susceptibility to infectious and inflammatory disease

      , 1 , 1 , 1 , 1 , 1 , 1

      Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology

      BioMed Central

      AllerGen NCE Inc.'s Fifth Annual Research Conference: Innovation from Cell to Society

      7-9 February 2010

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective/purpose Genetic association studies have identified several polymorphisms in genes of the innate immunity cascade that appear to influence susceptibility to asthma and other inflammatory diseases. However, most candidate genes have not been functionally characterized for their impact on human immune responsiveness. An excellent candidate for functional investigation is NFKBIA which encodes IκBα--the major negative regulator of NFκB. Single nucleotide polymorphisms (SNPs) in the promoter region of NFKBIA have been implicated in various infectious and inflammatory diseases. Specifically, the linked promoter SNPs rs2233406, rs3138053 and rs2233409 have been implicated in sarcoidosis, trachoma, acute respiratory distress syndrome, invasive pneumococcal disease, Graves' disease and respiratory syncytial virus. We investigated the mechanistic and functional impact of the promoter variants of NFKBIA on human immune responsiveness. Methods Using a coding SNP that was in high linkage with NFKBIA SNPs rs3138053/rs2233406/rs2233409, we designed and validated an allele-specific PCR assay that could detect subtle differences in allele ratios between the major (ACC) and minor (GTT) promoter variants of SNPs rs3138053/rs2233406/rs2233409. Peripheral blood mononuclear cells of homozygous (ACC/ACC) and heterozygous (ACC/GTT) individuals were stimulated with LPS and live cultures of Streptococcus pneumoniae (serotype 14) for 3 and 4 hours. PBMCs of NFKBIA homozygotes and heterozygotes were stimulated with various Toll-like-receptor (TLR) ligands of the innate immune cascade to assay for differences in the innate immune response. Findings NFKBIA heterozygotes (ACC/GTT) displayed 1.21 (1.14-1.27 95% CI) - 1.26 (1.18-1.34 95% CI) fold higher expression of the major allele transcript (ACC) relative to the minor allele transcript (GTT). At 3 hours post stimulation, NFKBIA homozygotes (ACC/ACC) produced higher level of NFKBIA mRNA than heterozygotes (ACC/GTT) following stimulation with LPS (1.4 fold, p = 0.0095) or S. pneumoniae (1.51 fold, p = 0.024). Higher TNF-α secretion was seen from the peripheral blood mononuclear cells (PBMCs) of heterozygotes (ACC/GTT) as compared to homozygotes (ACC/ACC) when stimulated with Pam3CSK4 (2.29-fold increase; p < 0.01) and 3M-002 (3.30-fold increase; p < 0.001). Deliverables We have shown that the observed association of NFKBIA variants with infectious and inflammatory conditions has functional consequences. Individuals heterozygous for SNPs rs3138053 /rs2233406/rs1050851 display allelic imbalance, reduced levels of NFKBIA expression, as well as a hyper inflammatory innate immune response. Relevance Functional genomic studies such as this will help realize AllerGen's goal of 'discovery of the causes of, and ways to prevent, control or eliminate allergic and related immune diseases' by: • Generating convincing evidence that the genetic variant is functionally relevant and likely to contribute to the development of the clinical phenotype. • Providing insight into the mechanism underlying the genetic association and, therefore, greatly enhancing our knowledge of the disease pathogenesis. • Identifying molecular pathways that can be targeted to prevent or treat allergic disease.

          Related collections

          Author and article information

          Conference
          Allergy Asthma Clin Immunol
          Allergy Asthma Clin Immunol
          Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
          BioMed Central
          1710-1484
          1710-1492
          2010
          26 November 2010
          : 6
          : Suppl 3
          : P2
          Affiliations
          [1 ]BC Children's Hospital and Child & Family Research Institute, University of British Columbia Supervisor: Stuart Turvey
          1710-1492-6-S3-P2
          10.1186/1710-1492-6-S3-P2
          3353440
          Copyright ©2010 Ali et al; licensee BioMed Central Ltd.
          AllerGen NCE Inc.'s Fifth Annual Research Conference: Innovation from Cell to Society
          Québec City, QC, Canada
          7-9 February 2010
          Categories
          Poster Presentation

          Immunology

          Comments

          Comment on this article